Impact of radiotherapy to the primary tumor on the efficacy of pembrolizumab for patients with advanced urothelial cancer: A preliminary study

Radiotherapy plus immune checkpoint inhibitors can potentially induce synergistic antitumor immune responses. However, little clinical evidence is established regarding their combination therapy. Here, we aimed to assess whether radiotherapy to the primary tumor impacts on the efficacy of pembrolizu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukushima, Hiroshi, Kijima, Toshiki, Fukuda, Shohei, Moriyama, Shingo, Uehara, Sho, Yasuda, Yosuke, Tanaka, Hajime, Yoshida, Soichiro, Yokoyama, Minato, Matsuoka, Yoh, Saito, Kazutaka, Matsubara, Nobuaki, Numao, Noboru, Sakai, Yasuyuki, Yuasa, Takeshi, Masuda, Hitoshi, Yonese, Junji, Kageyama, Yukio, Fujii, Yasuhisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666746/
https://www.ncbi.nlm.nih.gov/pubmed/32886446
http://dx.doi.org/10.1002/cam4.3445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666746/
https://www.ncbi.nlm.nih.gov/pubmed/32886446
http://dx.doi.org/10.1002/cam4.3445

Ejemplares similares